Skip to search formSkip to main contentSkip to account menu

psoralen A

Known as: 3-ethoxycarbonyl-2H-benzofuro(3,2-f)-1-benzopyran-2-one 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Furocoumarins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Characterization of PLGA Microparticles as a Drug Carrier for 3-Ethoxycarbonyl-2H-Benzofuro[3,2-f]-1-Benzopyran-2-One. Ultrastructural Study of Cellular Uptake and Intracellular Distribution
Here we describe the application of microparticles (MPs) for the delivery and release of the drug a benzopsoralen. We also… 
1994
1994
Dermatomyositis occurring during psoralen A (PUVA) therapy.
Dermatomyositis (DM) developed in a 35-year-old woman after 2 months of psoralen ultraviolet-A (PUVA) therapy for presumed… 
1994
1994
Dermatomyositis occurring during psoralen A (PUVA) therapy.
Dermatomyositis (DM) developed in a 35-year-old woman after 2 months of psoralen ultraviolet-A (PUVA) therapy for presumed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)